Altogether, our study findings preliminarily demonstrate that CTD inhibits proliferation and induces apoptosis of human oral cancer cells by targeting AKT to downregulate the expression of GSK3β, mTOR and TOPK, thus inhibiting cell growth, migration and apoptosis. This evidence concerns the gene GSK3B and lip and oral cavity carcinoma.